Clinical Trials Directory

Trials / Completed

CompletedNCT02653703

L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain

High-concentration L-menthol as a Counter-irritant to TRPA1-induced Neurogenic Inflammation, Thermal and Mechanical Hyperalgesia Caused by Trans-cinnamaldehyde

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Aalborg University · Academic / Other
Sex
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to quantitatively characterize the effects of L-menthol as a topical counter-irritant on cutaneous pain and hyperalgesia provoked by topical application of the TRPA1-agonist trans-cinnamaldehyde (CA) in healthy human volunteers.

Detailed description

This study is designed as an experimental model in healthy humans.

Conditions

Interventions

TypeNameDescription
OTHERTopical L-menthol 40%Naturally occurring local anaesthetic, counterirritant and TPRM8-agonist. CAS Number: 2216-51-5
OTHERVehicle, topical ethanol 96%Organic solvent CAS Number: 64-17-5

Timeline

Start date
2014-10-01
Primary completion
2014-12-01
Completion
2014-12-01
First posted
2016-01-12
Last updated
2016-01-12

Source: ClinicalTrials.gov record NCT02653703. Inclusion in this directory is not an endorsement.

L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain (NCT02653703) · Clinical Trials Directory